Browsing Category
S-4 Filing
961 posts
Technology & Telecommunication Acquisition Seeks Deadline Extension to January 2025
The SPAC in October 2022 announced a deal with Malaysia-based Super Apps Holdings Sdn Bhd at a pro forma enterprise value for the combined company of approximately $1.1 billion.
April 30, 2024
Clover Leaf Capital Files Prospectus on Kustom Entertainment Deal
Terms call for Kustom Entertainment shareholders to receive $125 million in stock.
April 29, 2024
99 Acquisition Files Prelim Proxy on Nava Health MD Merger
The target is a vertically integrated, tech-enabled chain of healthcare centers that combines integrative, functional, preventive, and regenerative medicine.
April 26, 2024
EVe Mobility Acquisition Seeks Approval for Another Extension
EVe originally raised $220 million in a December 2021 IPO to focus on the mobility-related ecosystem. It has yet to announce a deal.
April 26, 2024
Blue Ocean Acquisition Wants 6 More Months to Complete TNL Mediagene Deal
The SPAC raised $165 million in a December 2021 IPO, but lost about 83% of its trust to redemptions ahead of a May 2023 deadline extension vote. Blue Ocean currently holds about $65 million in trust.
April 26, 2024
Bellevue Life Sciences Acquisition Files Proxy on 6-Month Extension to Work on OSR Deal
The deal with the healthcare holding company was announced in November. Peter Kuk Hyoun Hwang is CEO of both companies.
April 26, 2024
Investcorp Europe I Asks Shareholders for 6 More Months to Close OpSec Deal
The target a global provider of brand protection solutions and intellectual property management.
April 25, 2024
Digital Health Files Proxy on $110M VSee & iDoc Deals
VSee Lab is a telehealth software company, and iDoc Telehealth is a neurocritical care and intensive care telehealth provider.
April 25, 2024
ARYA IV Updates Investor Presentation on Adagio Deal
The target develops catheter ablation technologies for treatment of cardiac arrhythmias.
April 24, 2024
Genesis Growth Tech Files Proxy on MindMaze Deal
MindMaze is a digital therapeutics firm. The SPAC is obligated to pay MindMaze the $21 million purchase price by May 31.
April 22, 2024